相关实验视频

Updated: Jan 16, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

儿科癌症的结构变化的景观

Robert Greenhalgh¹, Wentao Yang¹, Samuel W Brady^1,2

¹Department of Computational Biology, St. Jude Children's Research Hospital, Memphis TN, USA.

bioRxiv : the preprint server for biology

|October 1, 2025

概括

结构变异 (SV) 是儿科癌症的关键驱动因素. 这项研究揭示了与RAG介导重组相关的儿科白血病中独特的SV模式,为未来的癌症研究和基因组测试提供了洞察力.

科学领域:

基因组学就是基因组学.
癌症生物学癌症生物学
分子瘤学分子瘤学

背景情况:

结构变异 (SV) 是儿科癌症的主要驱动因素,通常是疾病的发病因子.
了解各种癌症类型的SV对于推进儿科瘤学至关重要.

研究的目的:

在儿科和成人癌症中全面分析和比较结构变异景观.
在儿科恶性瘤中识别独特的SV模式和突变特征,特别是急性淋巴细胞白血病 (ALL).

主要方法:

对16种类型的1,616个儿科癌症基因组进行分析,与2,203个成人癌症基因组相比.
识别和描述反复出现的SV热点,SV特征和突变过程.
使用空间时间上不同的样本进行患者内进化分析.

主要成果:

在儿童癌症中,SV负担在很大程度上有所不同,与成年人相比,大脑/固体瘤的发病率较低,但在血液性恶性瘤中发病率相似.
儿童ALLs在RAG介导的重组信号序列 (RSS) 附近呈现独特的SV热点,破坏免疫位点和69个基因.
确定了8种不同的SV特征,包括骨髓瘤中的集群转位和RAG介导的删除丰富癌症中中等大小的删除.
通过RAG介导的重组和复杂的重新排列发生在早期和持续的阶段,有助于克隆异质性.
驱动基因和脆弱部位是SVs最常破坏的基因组区域.

结论:

儿科癌症具有独特的SV景观,RAG介导的突变发生在ALL中发挥着重要作用.
这些发现扩大了对儿科ALL中SVs的理解,并为功能研究和临床基因组测试提供了宝贵的资源.
该研究强调了在基因组不稳定性和早期癌症发展的背景下考虑SV的重要性.

更多相关视频

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...